Pharma & Biotech

As U.S. markets operated on a shortened post-Thanksgiving schedule, research departments remained active, with Viking Therapeutics generating significant analyst enthusiasm....

Novo Nordisk's stock has entered a dramatic downturn, shedding more than half its value since the start of the year...

The independent existence of CureVac as a publicly traded company is drawing to a close. Following decisive shareholder approval, the...

A severe clinical setback has struck Intellia Therapeutics, sending its stock value tumbling after the U.S. Food and Drug Administration...

After experiencing significant declines earlier in the week, Novo Nordisk shares surged dramatically on Thursday, posting gains of up to...

Pharmaceutical giant Teva is experiencing a remarkable surge in its share price, yet a growing chorus of doubters is emerging...

Scilex Holding has finalized its $150 million strategic investment in Datavault AI through an unconventional payment structure that saw the...

Biotechnology firm Karyopharm Therapeutics finds itself navigating turbulent market conditions as its stock experiences a significant technical breakdown. The company's...

The biotechnology sector has identified its latest standout performer: Adma Biologics. This plasma-derived therapy specialist is commanding significant market attention,...

The German biotechnology firm BioNTech is on the verge of a significant strategic achievement, having successfully navigated the primary hurdle...